Not classified as an open-market trade.
Traded Dec 22, 2025 · Filed Dec 23, 2025
A board member of Nike spent $500K of their very own money to buy Nike shares. 2 other people at Nike bought some too, in the same month. Their pile of Nike shares grew by 25%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$500,080
Shares × reported transaction price
$500K–$1M
+25.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
4 days after results of Dec 18, 2025, 99 days before results of Mar 31, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $57.22 on Dec 22, 2025, 7% above its 52-week low and 30% below its high, after a 6% drop over the previous 30 trading days
52-week range $53.27 (Apr 8, 2025) to $81.72 (Feb 25, 2025), 14% of the way up, from 250 adjusted closes. 30 trading days earlier: $61.09 on Nov 7, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Jul 15, 2024 in the U.S. District Court, D. Oregon. A filing is an allegation, not a finding.
2 such cases were open. In re Nike Inc. Securities Litigation, docket 3:24-cv-01150, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.2% | -1.2% | +7.4% |
| 30 days | +8.4% | -0.2% | +8.6% |
| 90 days | -10.8% | -5.4% | -5.5% |
| 180 days | -28.0% | +7.8% | -35.8% |
Past results only. Not a forecast.
Not classified as an open-market trade.
Not classified as an open-market trade.
Not classified as an open-market trade.
Robert Holmes Swan, Director's past purchases, 90 days after disclosure: 3 buys, median -5.5% vs S&P 500, beat it 1 of 3 times. Past results, not a forecast.